You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory malignant lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed or Refractory Non-Hodgkin's Lymphoma, Relapsed or Refractory Multiple Myeloma Trial in Changsha (BEBT-908 for

Completed
  • Relapsed or Refractory Non-Hodgkin's Lymphoma
  • Relapsed or Refractory Multiple Myeloma
  • BEBT-908 for injection
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Oct 9, 2023

Recurrent/Refractory Malignant Lymphoma Trial in Beijing (JS004 , Recombinant humanized IgG4k mAb specific to BTLA for injection

Recruiting
  • Recurrent/Refractory Malignant Lymphoma
  • JS004 , Recombinant humanized IgG4k monoclonal antibody specific to BTLA for injection Intravenous infusion
  • Drugļ¼šJS001, Intravenous infusion
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Apr 13, 2022

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

    Recruiting
    • Advanced Lymphoma
    • +13 more
    • BET Bromodomain Inhibitor ZEN-3694
    • +2 more
    • New Haven, Connecticut
      Yale University Cancer Center LAO
    Jun 29, 2022

    Lymphoma Trial in Hangzhou (Autologous hematopoietic stem cell transplantation combined with CD19 CAR-T cells)

    Recruiting
    • Lymphoma
    • Autologous hematopoietic stem cell transplantation combined with CD19 CAR-T cells
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Feb 13, 2022

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Capivasertib)

    Active, not recruiting
    Has Results
    • Advanced Lymphoma
    • +5 more
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Jun 28, 2022

    Lymphoma, B-Cell, Leukemia, B-cell, Leukemia, T-Cell Trial in Cangzhou (CAR-T)

    Recruiting
    • Lymphoma, B-Cell
    • +3 more
    • CAR-T
    • Cangzhou, Hebei, China
      Cangzhou People's Hospital
    Nov 9, 2022

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Trametinib

    Active, not recruiting
    • Advanced Lymphoma
    • +5 more
    • Trametinib Dimethyl Sulfoxide
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Aug 13, 2022

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Defactinib

    Active, not recruiting
    • Advanced Lymphoma
    • +5 more
    • Defactinib Hydrochloride
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Jun 28, 2022

    Ex Vivo Drug Sensitivity Testing and Mutation Profiling

    Completed
    • Recurrent Childhood Acute Myeloid Leukemia
    • +13 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Jan 18, 2023

      Diffuse Midline Glioma, H3 K27M-Mutant, Metastatic Malignant Tumor in the CNS, Recurrent Diffuse Intrinsic Pontine Glioma Trial

      Active, not recruiting
      • Diffuse Midline Glioma, H3 K27M-Mutant
      • +10 more
      • FACT Complex-targeting Curaxin CBL0137
      • Birmingham, Alabama
      • +19 more
      Jun 29, 2022

      Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)

      Active, not recruiting
      • Advanced Lymphoma
      • +5 more
      • Philadelphia, Pennsylvania
        ECOG-ACRIN Cancer Research Group
      Jun 28, 2022

      Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Afatinib

      Active, not recruiting
      • Advanced Lymphoma
      • +5 more
      • Afatinib Dimaleate
      • Philadelphia, Pennsylvania
        ECOG-ACRIN Cancer Research Group
      Jun 28, 2022

      Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,

      Completed
      Has Results
      • Brain Stem Neoplasm
      • +9 more
      • Birmingham, Alabama
      • +20 more
      Jan 6, 2023

      Recurrent Lymphoma, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan,

      Active, not recruiting
      Has Results
      • Recurrent Lymphoma
      • +5 more
      • Birmingham, Alabama
      • +19 more
      Oct 20, 2022

      Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

      Recruiting
      • Colorectal Carcinoma
      • +21 more
      • Dual X-ray Absorptiometry
      • +2 more
      • Birmingham, Alabama
      • +18 more
      Jan 30, 2023

      Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

      Recruiting
      • Solid Tumor, Adult
      • +6 more
      • TP53-EphA-2-CAR-DC
      • +3 more
      • Beijing, Beijing, China
        Biotherapeutic Department of Chinsese PLA Gereral Hospital
      Nov 29, 2022

      Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor Trial in Philadelphia (Biopsy,

      Active, not recruiting
      • Advanced Lymphoma
      • +5 more
      • Biopsy
      • +3 more
      • Philadelphia, Pennsylvania
        ECOG-ACRIN Cancer Research Group
      Aug 5, 2022

      Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

      Active, not recruiting
      Has Results
      • Metastatic Melanoma
      • +22 more
      • Ipilimumab
      • +3 more
      • Birmingham, Alabama
      • +24 more
      Jan 19, 2023

      Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Taselisib)

      Active, not recruiting
      • Advanced Lymphoma
      • +5 more
      • Philadelphia, Pennsylvania
        ECOG-ACRIN Cancer Research Group
      Feb 4, 2022

      Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Crizotinib)

      Active, not recruiting
      • Advanced Lymphoma
      • +5 more
      • Philadelphia, Pennsylvania
        ECOG-ACRIN Cancer Research Group
      Feb 4, 2022

      Constitutional Mismatch Repair Deficiency Syndrome, Hematopoietic and Lymphoid Cell Tumor, Lynch Syndrome Trial in Canada,

      Withdrawn
      • Constitutional Mismatch Repair Deficiency Syndrome
      • +11 more
      • Biospecimen Collection
      • +2 more
      • Palo Alto, California
      • +8 more
      Sep 9, 2022

      Recurrent Alveolar Rhabdomyosarcoma, Recurrent Ewing Sarcoma, Recurrent Lymphoma Trial in United States (Elimusertib)

      Recruiting
      • Recurrent Alveolar Rhabdomyosarcoma
      • +7 more
      • Birmingham, Alabama
      • +28 more
      Jan 26, 2023

      AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United

      Recruiting
      • AIDS-Related Non-Hodgkin Lymphoma
      • +29 more
      • Laboratory Biomarker Analysis
      • Pembrolizumab
      • Birmingham, Alabama
      • +12 more
      Aug 4, 2022

      Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor Trial in Australia, Canada, United States (CLR 131)

      Recruiting
      • Pediatric Solid Tumor
      • +7 more
      • CLR 131
      • Palo Alto, California
      • +6 more
      Nov 30, 2021